Research suggests that racial and ethnic disparities exist in the prevalence and treatment of type 2 diabetes. The role of visceral fat in these disparities is being explored, and studies indicate that minority communities are disproportionately affected by the disease. The causes of these disparities are complex and may involve factors such as unequal access to medication and care, as well as structural racism.